Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 334 on Exercise Time During a Treadmill Test in Subjects With Stable Angina

NCT02575833 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02575833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02575833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of AMG 334 on Exercise Time During a Treadmill Test in Subjects With Stable Angina
Lead sponsor
Amgen
Phase
Phase 2
Overall status
Completed
Start date
November 23, 2015
Completion date
April 13, 2017
Enrollment
89 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

stable angina